The treatment of high grade superficial bladder cancer and carcinoma in situ with BCG - A questionnaire survey of consultant practice in England and Wales

Jon Paul Meyer*, Rajendra Persad, John L. Probert, David A. Gillat

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Objective: To assess consultant practices and attitudes concerning the use of intravesical BCG for CIS, and high grade superficial TCC bladder in England and Wales. Materials and methods: Consultants in England and Wales, identified from the BAUS members handbook were sent a questionnaire survey to determine their usage of BCG and the reasons why they adopted their chosen practice. Results: Three hundred and sixteen completed questionnaires were returned, giving a response rate for the questionnaire of 70%. Although, the vast majority adopted a regimen of a weekly instillation of BCG for 6 weeks for an initial treatment course, the practice of maintenance therapy varied nationally. In addition to this, initial follow up of BCG patients, and how to manage the BCG "failures" also differed amongst consultant urologists in England and Wales. Conclusions: In patients receiving BCG, a consensus view should be sought to determine optimal management.

Original languageEnglish
Pages (from-to)77-80
Number of pages4
JournalUroOncology
Volume2
Issue number2
DOIs
Publication statusPublished - Jun 2002
Externally publishedYes

Keywords

  • Bacille Calmette-Guerin
  • Carcinoma-in-situ
  • Consultant urologists
  • Questionnaire
  • Transitional cell carcinoma

Fingerprint Dive into the research topics of 'The treatment of high grade superficial bladder cancer and carcinoma in situ with BCG - A questionnaire survey of consultant practice in England and Wales'. Together they form a unique fingerprint.

Cite this